An Accessible Organotypic Microvessel Model Using iPSC‐Derived Endothelium. Issue 2 (7th August 2017)

• Record Type: Journal Article
• Authors: Ingram, Patrick N.; Hind, Laurel E.; Jiminez‐Torres, Jose A.; Huttenlocher, Anna; Beebe, David J.
• Is Part Of: Advanced healthcare materials. Volume 7:Issue 2(2018)
• Page Start: n/a
• Page End: n/a
• Publication Date: 2017-08-07
• Subjects: endothelial cells -- induced pluripotent stem cells -- in vitro modeling -- neutrophils -- organotypic/organ‐on‐a‐chip; Biomedical materials -- Periodicals; 610.28
• DOI: 10.1002/adhm.201700497
• Languages: English
• ISSNs: 2192-2640

Abstract

Abstract: While organotypic approaches promise increased relevance through the inclusion of increased complexity (e.g., 3D extracellular microenvironment, structure/function relationships, presence of multiple cell types), cell source is often overlooked. Induced pluripotent stem cell (iPSC)‐derived cells are potentially more physiologically relevant than cell lines, while also being less variable than primary cells, and recent advances have made them commercially available at costs similar to cell lines. Here, the use of induced pluripotent stem cell‐derived endothelium for the generation of a functional microvessel model is demonstrated. High precision structural and microenvironmental control afforded by the design approach synergizes with the advantages of iPSC to produce microvessels for modeling endothelial biology in vitro. iPSC microvessels show endothelial characteristics, exhibit barrier function, secrete angiogenic and inflammatory mediators, and respond to changes in the extracellular microenvironment by altering vessel phenotype. Importantly, when deployed in the investigation of neutrophils during innate immune recruitment, the presence of the iPSC endothelial vessel facilitates neutrophil extravasation and migration toward a chemotactic source. Relevant cell sources, such as iPSC, combine with organotypic models to open the way for improved and increasingly accessible in vitro tissue, disease, and patient‐specific models. Abstract : Improved cell sources, such as induced pluripotent stem cells (iPSCs), are critical complements to the increased relevance organotypic in vitro models provide. Coupling a robust 3D lumen microfabrication approach with iPSC‐derived endothelium, a functional in vitro endothelial vessel is presented that provides structure, regulates barrier function, secretes cytokines, and is capable of supporting innate immune modeling.